|Articles|March 1, 2003
Rapid Response Therapy
Winston-Salem, N.C. - Even before lesions begin to improve, patients with moderate to severe plaque psoriasis feel better a few weeks after starting efalizumab (Raptiva) therapy.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
2
A Patient–Physician Lens on the Real Burden of CHE
3
Celldex Advances Barzolvolimab into Phase 3 for Cold Urticaria and Symptomatic Dermographism
4
New Perspectives in Chronic Hand Eczema Care
5















